Recruiting
Acute myeloid leukaemia refractory+1
RecruitingStudy on the Safety and Effectiveness of Eltanexor for Patients with Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia
InvestigationalNo placebo
Study on the Safety and Effectiveness of Eltanexor for Patients with Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia
InvestigationalNo placebo
- Disease:Acute myeloid leukaemia refractoryAcute myeloid leukaemia recurrent
- Substances:Eltanexor
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Substances:Eltanexor
